Preimplantation Genetic Testing for Monogenic Kidney Disease

Abstract

Background and objectivesA genetic cause can be identified for an increasing number of pediatric and adult-onset kidney diseases. Preimplantation genetic testing (formerly known as preimplantation genetic diagnostics) is a reproductive technology that helps prospective parents to prevent passing on (a) disease-causing mutation(s) to their offspring. Here, we provide a clinical overview of 25 years of preimplantation genetic testing for monogenic kidney disease in The Netherlands.Design, setting, participants, & measurements This is a retrospective cohort study of couples counseled on preimplantation genetic testing for monogenic kidney disease in the national preimplantation genetic testing expert center (Maastricht University Medical Center+) from January 1995 to June 2019. Statistical analysis was performed through chi-squared tests.ResultsIn total, 98 couples were counseled regarding preimplantation genetic testing, of whom 53% opted for preimplantation genetic testing. The most frequent indications for referral were autosomal dominant polycystic kidney disease (38%), Alport syndrome (26%), and autosomal recessive polycystic kidney disease (9%). Of couples with at least one preimplantation genetic testing cycle with oocyte retrieval, 65% experienced one or more live births of an unaffected child. Of couples counseled, 38% declined preimplantation genetic testing for various personal and technical reasons.ConclusionsReferrals, including for adult-onset disease, have increased steadily over the past decade. Though some couples decline preimplantation genetic testing, in the couples who proceed with at least one preimplantation genetic testing cycle, almost two thirds experienced at least one live birth rate.

Genetic kidney diseases as an underrecognized cause of chronic kidney disease: the key role of international registry reports

“…One of the most relevant consequences of reaching a diagnosis of an IKD is the possibility of offering genetic counselling, including pre-symptomatic testing that may provide strategies and reproductive options to prevent passage of the disease to new generations, e.g. prenatal diagnosis or pre-implantation genetic testing [ 54 ]. The diagnosis of a rare IKD also allows patients to access reference centres that are used to manage their disease and can provide up-to-date information and management.…”

Molecular Basis, Diagnostic Challenges and Therapeutic Approaches of Bartter and Gitelman Syndromes: A Primer for Clinicians

“…Additionally, in GS, prenatal tests would be of great value [ 129 ] since some cases have been reported and diagnosed during pregnancy [ 130 , 131 ], with episodes of hypokalemia and salt craving. Nevertheless, as we will discuss later, genetic testing is not without problems and a conclusive diagnosis is not always achieved.…”

Update on genetic screening and treatment for infertile men with genetic disorders in the era of assisted reproductive technology

“…Common indications for PGT-M include cystic fibrosis, spinal muscular atrophy, hereditary hemoglobinopathies, and Huntington disease; however, its indications are rapidly expanding in the post-human genome sequencing era. The transmission of genetic urological disorders, such as Alport syndrome, autosomal dominant polycystic kidney disease, and Von Hippel-Lindau syndrome, could also be prevented by IVF-ICSI and PGT-M [ 76 , 77 ]. Many single-gene mutations linked with spermatogenesis (e.g., mutations in X-linked, Y-linked, and autosomal genes) could be detected by PGT-M, enabling the prevention of disease complications ( Table 3 ).…”